Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1176

Sort by

Sort Order Select

Journal Articles

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism

Blood (2021) 137 (19): 2681–2693.

https://doi.org/10.1182/blood.2019004571

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Blood (2021) 137 (15): 2103–2113.

https://doi.org/10.1182/blood.2020007488

Published: 2021

Includes: Supplemental data

Journal Articles

High Rates of Venous and Arterial Thrombotic Events in POEMS Patients: Results from the UK-Based POEMS Registry, Highlighting the Need for Therapeutic Guidelines

Zara Sayar, MD FRCPath, MRCP, Anna Weatherill, Stephen Keddie, Jonathan Sive, MD, Michael P Lunn, Mari Thomas, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 714.

https://doi.org/10.1182/blood-2019-125639

Published: 2019

Journal Articles

Characteristics of Inferior Vena Cava Filter Placement, Management, and Retrieval at a Multi-Center Institution

Charis Durham, MD, Kelsey Reely, DO, Wencong Chen, PhD, Lucas Wong, MD, Bryce Betteridge, MD

Blood (2019) 134 (Supplement_1): 1157.

https://doi.org/10.1182/blood-2019-124856

Published: 2019

Journal Articles

Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma

Alex F. Herrera, MD, Lu Chen, PhD, Leslie L. Popplewell, MD FRCPA, Lihua E Budde, MD PhD, Matthew Mei, MD, Saro H. Armenian, DO, MPH, Justin Darrah, MD, Liana Nikolaenko, MD, Robert W. Chen, MD, Lacolle Peters, Neena Kennedy, Steven Rosen, MD, Stephen J Forman, MD, Larry W Kwak, MD PhD

Blood (2019) 134 (Supplement_1): 759.

https://doi.org/10.1182/blood-2019-123163

Published: 2019

Journal Articles

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Aleksandra Kajetanowicz, BSc, Sudeep P Shivakumar, MD BSc, Steve Doucette, MSc, Susan Pleasance, BSN, Christopher Green, MD, Allen Tran, MDBSc, David R. Anderson, MD

Blood (2019) 134 (Supplement_1): 1148.

https://doi.org/10.1182/blood-2019-129140

Published: 2019

Journal Articles

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Jennifer G. Davila, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D. Thornburg, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 1156.

https://doi.org/10.1182/blood-2019-128324

Published: 2019

Journal Articles

Survival Pattern Among Venous Thromboembolism (VTE) Patients with Hematologic Malignancy in Alberta, Canada from 2003 to 2015

Arafat Ul Alam, MBBS, Mohammad Karkhaneh, PhD, Cynthia M. Wu, MD FRCPC, Haowei Linda Sun, MDFRCPC

Blood (2019) 134 (Supplement_1): 933.

https://doi.org/10.1182/blood-2019-126119

Published: 2019

Journal Articles

Inferior Vena Cava Filter Retrieval Trends: A Single Center Experience

Filip Ionescu, MD, Nwabundo Anusim, MD, Eva Ma, MD, Lihua Qu, MD MIS, Leann Blankenship, MD, Michael Stender, MD, Ishmael Jaiyesimi, DO, MS

Blood (2019) 134 (Supplement_1): 4690.

https://doi.org/10.1182/blood-2019-129366

Published: 2019

Journal Articles

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

Radhika Gangaraju, MD, Smita Bhatia, MDMPH, Kelly Kenzik, PhD

Blood (2019) 134 (Supplement_1): 4679.

https://doi.org/10.1182/blood-2019-124464

Published: 2019

Journal Articles

A Phase 1, Open-Label, Multi-Center Study of Alteminostat (CKD-581) in Combination with Lenalidomide and Dexamethasone in Patients with Previously Treated Multiple Myeloma (MM)

Chang Ki Min, MD PhD, Kihyun Kim, MD PhD, Seok Jin Kim, MD PhD, Dok Hyun Yoon, Sung-Soo Park, Seunghoon Han, MD PhD

Blood (2019) 134 (Supplement_1): 1847.

https://doi.org/10.1182/blood-2019-127643

Published: 2019

Journal Articles

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Damon E. Houghton, MDMS, Jordan Cochuyt, David O. Hodge, MS, Danielle Vlazny, PA-C, Ana I Casanegra, MD, Lisa Peterson, RN, David A Froehling, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2019) 134 (Supplement_1): 2158.

https://doi.org/10.1182/blood-2019-125099

Published: 2019

Journal Articles

The Role of Medical Comorbidities and Socioeconomic Factors in the Prevalence of Venous Thromboembolism Among Different Ethnic/Racial Groups in a Hospitalized Population

Iberia R Sosa, MD, Courtney Nicole Miller-Chism, MD, Jason L Salemi, PhD

Blood (2019) 134 (Supplement_1): 2160.

https://doi.org/10.1182/blood-2019-129142

Published: 2019

Journal Articles

Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial

Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Alexander T Cohen, MBBS, MSc, MD

Blood (2019) 134 (Supplement_1): 2161.

https://doi.org/10.1182/blood-2019-126810

Published: 2019

Journal Articles

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Brett Slajus, Yevgeniy Brailovsky, DO, Trung Phan, Iman Darwish, Jawed Fareed, PhD, Amir Darki, MD MSc

Blood (2019) 134 (Supplement_1): 2103.

https://doi.org/10.1182/blood-2019-127425

Published: 2019

Journal Articles

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Michael H. White, MD, Gary Woods, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2179.

https://doi.org/10.1182/blood-2019-130100

Published: 2019

Journal Articles

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Jeremy Y Feng, MD, Charles B Ross, MD FACS, FSVS, Rachel P Rosovsky, MDMPH

Blood (2019) 134 (Supplement_1): 3409.

https://doi.org/10.1182/blood-2019-125493

Published: 2019

Journal Articles

Identifying miRNA Biomarkers and Predicted Targets Associated with Venous Thromboembolism in Colorectal Cancer Patients

Ann S. Kim, BA, Matthew F Kalady, MD, Jennifer DeVecchio, Kahraman Tanriverdi, Jane E. Freedman, MD, John Barnard, PhD, Tae Hyun Hwang, PhD, Alok A Khorana, MD, Keith R McCrae, MD

Blood (2019) 134 (Supplement_1): 3643.

https://doi.org/10.1182/blood-2019-127585

Published: 2019

Journal Articles

Inflammasome Activation Promotes Deep Vein Thrombosis through Pyroptosis

Yan Zhang, Guoying Zhang, Cui Jian, Congqing Wu, PhD, Nigel Mackman, PhD, Susan Smyth, MD PhD, Yinan Wei, Zhenyu Li, PhD

Blood (2019) 134 (Supplement_1): 3644.

https://doi.org/10.1182/blood-2019-130439

Published: 2019

Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2019) 134 (Supplement_1): 3673.

https://doi.org/10.1182/blood-2019-128581

Published: 2019

NARROW

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

High Rates of Venous and Arterial Thrombotic Events in POEMS Patients: Results from the UK-Based POEMS Registry, Highlighting the Need for Therapeutic Guidelines

Characteristics of Inferior Vena Cava Filter Placement, Management, and Retrieval at a Multi-Center Institution

Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Survival Pattern Among Venous Thromboembolism (VTE) Patients with Hematologic Malignancy in Alberta, Canada from 2003 to 2015

Inferior Vena Cava Filter Retrieval Trends: A Single Center Experience

Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia

A Phase 1, Open-Label, Multi-Center Study of Alteminostat (CKD-581) in Combination with Lenalidomide and Dexamethasone in Patients with Previously Treated Multiple Myeloma (MM)

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

The Role of Medical Comorbidities and Socioeconomic Factors in the Prevalence of Venous Thromboembolism Among Different Ethnic/Racial Groups in a Hospitalized Population

Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Identifying miRNA Biomarkers and Predicted Targets Associated with Venous Thromboembolism in Colorectal Cancer Patients

Inflammasome Activation Promotes Deep Vein Thrombosis through Pyroptosis

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only